Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BUZZ - Disc Medicine shares drop after launching $350 million stock offering

BUZZ - Disc Medicine shares drop after launching $350 million stock offering

路透社路透社2026/10/19 20:36
Show original

- ** Shares of Disc Medicine’s IRON.O fell 1.5% in after-hours trading to $77.77 as the company plans an equity financing

** The biopharmaceutical company (link) launched a $350 million financing plan, including stock and pre-funded warrants

** IRON shares closed up 38.9% on Monday at $78.93, after its drug bitopertin (link) met all primary and secondary endpoints in a late-stage trial for erythropoietic protoporphyria (EPP), a blood disorder that makes patients extremely sensitive to sunlight

** The successful late-stage clinical trial (link) paves the way for the company to resubmit bitopertin to the U.S. Food and Drug Administration (FDA) for review—after the regulator rejected its application earlier this year

** IRON will use the net proceeds from this offering to fund research and development of its existing or new drug candidates, to support the potential commercialization of bitopertin for EPP and X-linked protoporphyria (XLP), and for other purposes

** Jefferies, Leerink, Morgan Stanley, and Cantor Fitzgerald are acting as joint bookrunners

** Massachusetts-based IRON has approximately 38.4 million shares outstanding and a market capitalization of about $3 billion

** According to LSEG data, all 13 analysts covering the stock have a bullish view; the median target price is $117.50



(To assist non-English speakers, Reuters delivers this report with an automatic translation into several other languages. Automatic translation may contain errors or lack necessary context, and Reuters does not guarantee the accuracy of the translated text. The automatic translation is provided solely for reader convenience. Reuters is not liable for any damages or losses arising from the use of automatic translations.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Masayoshi Son's Trillion-Dollar Gamble: Once Considered Acquiring SK Hynix

According to reports, Masayoshi Son once planned to acquire the South Korean memory chip giant SK Hynix for nearly 1 trillion US dollars and had approached Wall Street institutions to seek financing, but SoftBank has confirmed it is no longer actively pursuing the deal. The massive financing requirement and South Korean regulatory restrictions were major obstacles. This plan also highlights SoftBank’s further strategic intention to invest in AI storage chips.

华尔街见闻•2026/11/21 03:16

"Sell-offs bring more sell-offs! Goldman Sachs predicts another large-scale sell-off in the U.S. stock market in the coming week."

Goldman Sachs stated that the bank’s “panic index” has risen to 9 out of 10, with systemic selling pressure continuing to spread. In the coming week, CTAs may sell up to $80.6 billion in US stocks, and even if the market remains flat, there is still $65.8 billion in sell orders waiting to be executed. The Anthropic IPO failed to boost market risk appetite, and concerns over AI investment returns continue to weigh on tech stock valuations.

华尔街见闻•2026/11/21 02:16